| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/20/1997 | WO1997006272A2 High efficiency helper system for aav vector production |
| 02/20/1997 | WO1997006269A1 Inducible herbicide resistance |
| 02/20/1997 | WO1997006268A2 Dna constructs |
| 02/20/1997 | WO1997006267A2 Genetic transformation using a parp inhibitor |
| 02/20/1997 | WO1997006266A1 Vectors and process for producing high purity 6,12-dideoxyerythromycin a by fermentation |
| 02/20/1997 | WO1997006259A2 Resistance against wilt inducing fungi |
| 02/20/1997 | WO1997006256A2 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006250A1 Nuclear-encoded transcription system in plastids of higher plants |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997006241A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | WO1997006240A1 Reversible membrane insert for growing tissue cultures |
| 02/20/1997 | WO1997006176A2 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 02/20/1997 | WO1997002730A3 Enamel matrix related polypeptide |
| 02/20/1997 | DE19530412A1 Selbst deletierende retrovirale Vektoren für die Gentherapie Even deletierende retroviral vectors for gene therapy |
| 02/20/1997 | CA2512366A1 Mammalian iap gene family, primers, probes and detection methods |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | CA2228999A1 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis |
| 02/20/1997 | CA2228512A1 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 02/20/1997 | CA2227584A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | CA2227524A1 Resistance against wilt inducing fungi |
| 02/20/1997 | CA2227445A1 Dna constructs |
| 02/20/1997 | CA2224732A1 Inducible herbicide resistance |
| 02/20/1997 | CA2201481A1 Vectors and process for producing high purity 6,12-dideoxyerythromycin a by fermentation |
| 02/19/1997 | EP0758397A1 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 02/19/1997 | EP0758394A1 Bifunctional protein, preparation and use |
| 02/19/1997 | EP0758390A1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/19/1997 | EP0758387A1 Thymidine kinase mutants |
| 02/19/1997 | EP0758385A1 Chimeric delta-endotoxin expression in pseudomonas fluorescens |
| 02/19/1997 | EP0758382A1 Enhancing the sensitivity of tumor cells to therapies |
| 02/19/1997 | EP0758376A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 02/19/1997 | EP0730404A4 Amphiphilic imidazolinium derivatives |
| 02/19/1997 | CN1143372A Haemopoietic manuration factor |
| 02/19/1997 | CN1143371A Corpuscles of stannius protein, stanniocalcin |
| 02/19/1997 | CN1143116A New human erythropoietin |
| 02/19/1997 | CN1034055C Monoclone antibody used for preparing medicine of therapeutic imflammation region |
| 02/18/1997 | US5604201 Methods and reagents for inhibiting furin endoprotease |
| 02/18/1997 | US5604125 Culturing coniferous plant tissue in aqueous medium having controlled amounts of nitrogen, phosphate, ammonium, iron and potassium compounds, also with arginine and ethylenediaminetetraacetaic acid as chelating agent |
| 02/18/1997 | US5604121 Proteins with insecticidal properties against homopteran insects and their use in plant protection |
| 02/18/1997 | US5604116 Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods |
| 02/18/1997 | US5604115 Liver enriched transcription factor |
| 02/18/1997 | US5604094 Receptor-type phosphotyrosine phosphatase-β |
| 02/13/1997 | WO1997005266A1 Methods and means for targeted gene delivery |
| 02/13/1997 | WO1997005265A1 Transport proteins and their uses |
| 02/13/1997 | WO1997005263A1 Helper virus-free herpesvirus vector packaging system |
| 02/13/1997 | WO1997005261A1 Root cortex specific gene promoter |
| 02/13/1997 | WO1997005256A2 Mammalian pro-hormone convertase |
| 02/13/1997 | WO1997005255A2 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | WO1997005254A1 CYTIDINE DEAMINASE cDNA AS A POSITIVE SELECTABLE MARKER FOR GENE TRANSFER, GENE THERAPY AND PROTEIN SYNTHESIS |
| 02/13/1997 | WO1997005252A2 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/13/1997 | WO1997005250A2 Receptor ligand vegf-c |
| 02/13/1997 | WO1997005247A1 Transgenic 'knock out' mice expressing a human apolipoprotein e |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005240A1 Regulated autocrine growth of mammalian cells |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997005238A1 Site-directed bone formation |
| 02/13/1997 | WO1997005170A2 Broad specificity antibodies |
| 02/13/1997 | WO1997005169A1 Ha-2 antigenic peptide |
| 02/13/1997 | WO1997005168A1 The h-y antigen |
| 02/13/1997 | WO1997004720A1 The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| 02/13/1997 | WO1997004647A1 Methods of detecting duplication mutated fibrillin-1 gene and compositions and methods of using the same |
| 02/13/1997 | WO1996040951A3 Use of ovary-tissue transcriptional factors |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | WO1996013583A3 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 02/13/1997 | DE19529696A1 Transgene Pflanzenzellen und Pflanzen mit gesteigerter Glykolyserate Transgenic plant cells and plants with increased glycolysis |
| 02/13/1997 | CA2228378A1 Cytidine deaminase cdna as a positive selectable marker for gene transfer, gene therapy and protein synthesis |
| 02/13/1997 | CA2228248A1 Receptor ligand vegf-c |
| 02/13/1997 | CA2227988A1 Mammalian pro-protein converting enzyme |
| 02/13/1997 | CA2227786A1 Transport proteins and their uses |
| 02/13/1997 | CA2227784A1 Site-directed bone formation |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227599A1 Broad specificity antibodies |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2227007A1 Transgenic "knock out" mice expressing a human apolipoprotein e |
| 02/13/1997 | CA2225551A1 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | CA2224909A1 Ha-2 antigenic peptide |
| 02/13/1997 | CA2224907A1 Methods and means for targeted gene delivery |
| 02/13/1997 | CA2224894A1 The h-y antigen |
| 02/13/1997 | CA2200606A1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/12/1997 | EP0757720A1 Trimerising polypeptides, their manufacture and use |
| 02/12/1997 | EP0757719A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY |
| 02/12/1997 | EP0757718A1 Methods of use of uncoated gel particles |
| 02/12/1997 | EP0757717A1 Papillomavirus vaccines |
| 02/12/1997 | EP0757716A1 Dna encoding bradykinin b 1? receptor |
| 02/12/1997 | EP0470184B1 Antibodies specific for cd4-binding domain of hiv |
| 02/12/1997 | CN1142855A Humanized antibodies and uses thereof |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142829A Compounds and methods for site-directed mutations in eukaryotic cells |
| 02/11/1997 | US5602301 Non-human mammal having a graft and methods of delivering protein to myocardial tissue |
| 02/11/1997 | US5602242 Genetic engineered, encapsidated protein shell transfecting the plant cells |
| 02/11/1997 | US5602139 Method for ameliorating the adverse effects of aging |
| 02/11/1997 | US5602096 Contacting cell with glial growth factor |
| 02/11/1997 | US5602029 Method for fabricating substrate for cell culture and method for cell arrangements |
| 02/11/1997 | US5602027 Cell line TriH8 obtained by the fusion of the human epidermoid carcinoma cell line A431 with the TOS/H8 hybridoma |
| 02/11/1997 | US5602026 Culturing liver cells between two supports |
| 02/11/1997 | US5602025 Growth in serum-free media |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5602010 DNA encoding equine-gamma interferon and recombinant production of equine IFN-γ polypeptides |
| 02/11/1997 | US5602008 Genetic engineering |
| 02/11/1997 | US5602007 Recombinant DNA molecules |